101 related articles for article (PubMed ID: 9042235)
1. L-histidinol reverses resistance to cisplatinum and other antineoplastics in a tumorigenic epithelial cell line.
Warrington RC; Fang WD; Zhang LU
Anticancer Res; 1996; 16(6B):3641-6. PubMed ID: 9042235
[TBL] [Abstract][Full Text] [Related]
2. Mimetics of L-histidinol which selectively modulate daunomycin toxicity in normal and tumorigenic epithelial cells.
Warrington RC; Fang WD; Zhang L; Shieh M; Saier MH
Anticancer Res; 1996; 16(6B):3635-9. PubMed ID: 9042234
[TBL] [Abstract][Full Text] [Related]
3. L-histidinol selectively modulates daunomycin toxicity in normal and tumorigenic kidney epithelial cells.
Warrington RC; Fang WD; Zhang L; Shieh M; Saier MH
Anticancer Res; 1996; 16(6B):3629-33. PubMed ID: 9042233
[TBL] [Abstract][Full Text] [Related]
4. Effects of L-histidinol on the susceptibility of P815 mastocytoma cells to selected anticancer drugs in vitro and in DBA/2J mice.
Warrington RC; Cheng I; Fang WD
J Natl Cancer Inst; 1987 Jun; 78(6):1177-83. PubMed ID: 3108563
[TBL] [Abstract][Full Text] [Related]
5. A novel approach for improving the efficacy of experimental cancer chemotherapy using combinations of anticancer drugs and L-histidinol.
Warrington RC
Anticancer Res; 1986; 6(3 Pt B):451-64. PubMed ID: 3090929
[TBL] [Abstract][Full Text] [Related]
6. L-histidinol increases the vulnerability of cultured human leukemia and lymphoma cells to anticancer drugs.
Warrington RC; Cheng I; Zhang L; Fang WD
Anticancer Res; 1993; 13(6A):2107-12. PubMed ID: 8297120
[TBL] [Abstract][Full Text] [Related]
7. L-histidinol protection against cytotoxic action of cytosine arabinoside and 5-fluorouracil in cultured mouse spleen cells.
Warrington RC; Fang WD
J Natl Cancer Inst; 1982 Feb; 68(2):279-86. PubMed ID: 6950159
[TBL] [Abstract][Full Text] [Related]
8. Histidinol-mediated improvement in the specificity of 1-beta-D-arabinofuranosylcytosine and 5-fluorouracil in L 1210 leukemia-bearing mice.
Warrington RC; Muzyka TG; Fang WD
Cancer Res; 1984 Jul; 44(7):2929-35. PubMed ID: 6722819
[TBL] [Abstract][Full Text] [Related]
9. Effects of L-histidinol on the proliferation and anticancer drug susceptibility of cultured B16f10 melanoma cells.
Warrington RC; Cheng I; Fang W
Anticancer Res; 1991; 11(5):1863-7. PubMed ID: 1768057
[TBL] [Abstract][Full Text] [Related]
10. Histidinol-mediated enhancement of the specificity of two anticancer drugs in mice bearing leukemic bone marrow disease.
Warrington RC; Fang WD
J Natl Cancer Inst; 1985 May; 74(5):1071-7. PubMed ID: 3858576
[TBL] [Abstract][Full Text] [Related]
11. Reversal of the multidrug-resistant phenotype of Chinese hamster ovary cells by L-histidinol.
Warrington RC; Fang WD
J Natl Cancer Inst; 1989 May; 81(10):798-803. PubMed ID: 2716073
[TBL] [Abstract][Full Text] [Related]
12. Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
Sawyer RC; Stolfi RL; Martin DS
Cancer Res; 1988 Dec; 48(23):6664-8. PubMed ID: 2460227
[TBL] [Abstract][Full Text] [Related]
13. Development of multidrug resistance in a canine lymphoma cell line.
Uozurmi K; Nakaichi M; Yamamoto Y; Une S; Taura Y
Res Vet Sci; 2005 Jun; 78(3):217-24. PubMed ID: 15766940
[TBL] [Abstract][Full Text] [Related]
14. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of human colon carcinoma cells to anticancer drugs is enhanced by L-histidinol.
Warrington RC; Cheng I; Fang WD
Anticancer Res; 1994; 14(2A):367-72. PubMed ID: 8017835
[TBL] [Abstract][Full Text] [Related]
16. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
Wang W; Liu G; Zheng J
Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
[TBL] [Abstract][Full Text] [Related]
17. Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell kill.
Schenk PW; Brok M; Boersma AW; Brandsma JA; Den Dulk H; Burger H; Stoter G; Brouwer J; Nooter K
Mol Pharmacol; 2003 Aug; 64(2):259-68. PubMed ID: 12869630
[TBL] [Abstract][Full Text] [Related]
18. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
[TBL] [Abstract][Full Text] [Related]
19. Induction of chemoresistance in a cultured canine cell line by retroviral transduction of the canine multidrug resistance 1 gene.
Matsuura S; Koto H; Ide K; Fujino Y; Setoguchi-Mukai A; Ohno K; Tsujimoto H
Am J Vet Res; 2007 Jan; 68(1):95-100. PubMed ID: 17199425
[TBL] [Abstract][Full Text] [Related]
20. 1,4-Bis(1-naphthyl)-2,3-dinitro-1,3-butadiene a novel anticancer compound effective against tumor cell lines characterized by different mechanisms of resistance.
Novi M; Ottone M; Dell'Erba C; Barbieri F; Chiavarina B; Maccagno M; Viale M
Oncol Rep; 2004 Jul; 12(1):91-6. PubMed ID: 15201965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
